Chelsea Therapeutics International Ltd. (NASDAQ:CHTP)
CAPS Rating:
A development stage pharmaceutical company that seeks to acquire and develop innovative products for the treatment of a variety of human diseases.
A development stage pharmaceutical company that seeks to acquire and develop innovative products for the treatment of a variety of human diseases.
Recs
Hard to know for sure, but gut says investors are overreacting to the company's characterization of the ad com docs.